Finance News – Regeneron Pharmaceuticals
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Shares
Crypto Assets
Stock
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Stablecoin
Blockchain
Etf
Sec
Eth
Bse
Ipo
Trade
Solana
Index
Earnings
Inflation
Revenue
Coinbase
Interest Rates
China
Token
Wall Street
Nasdaq
Sensex
Federal Reserve
Gold
Treasury
Traders
Nse
Usd
Economy
Bse Sensex
Trade War
Profit
Tesla
Sp 500
Digital Assets
Economic Power
Health Insurer
Sui Dex
Nodal Clear
Films
Mainland China
Milestone Income
Matchwornshirt
Game Developers
Pune
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • May 27, 2025
23andMe to delist from Nasdaq, deregister with SEC
The planned acquisition of most 23andMe assets by Regeneron Pharmaceuticals for $256 million will result in the company's withdrawal from public stock trading and regulatory report...
Read Full Article →